Want to join the conversation?
For FY17, $VSTO expects sales of $2.72-2.78Bil. Interest expense is expected to be approx. $45MM and tax rate is expected to be approx. 37%. $VSTO expects adjusted EPS of $2.65-2.85. Capex is expected to be approx. $90MM. Free cash flow is expected to be $130-160MM.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.